Vial Announces $67M Series B Led by General Catalyst
Read Vial's feature in the WSJ

White Paper:
How Vial Revolutionized Patient Recruiting Using Multi-Channel Strategy and Powerful Technology

Clinical trial participation is critical for developing new medical treatments. However, patient recruitment comes with complex challenges that can make or break a trial’s success. Vial is committed to bridging the recruitment gap by implementing effective and efficient approaches to guarantee fulfilled trial participation goals quicker and with diverse patient representation.

This white paper will cover:

  • Vial’s multi-channel strategy for recruitment
  • Technology driven conversions
  • Advanced patient matching tactics for successful enrollment